{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:13:35Z","timestamp":1787008415769,"version":"build-2736575974"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 AG016574"],"award-info":[{"award-number":["P50 AG016574"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000867","name":"Robert Wood Johnson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000867","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016293","name":"Elsie and Marvin Dekelboum Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016293","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Liston Family Foundation"},{"DOI":"10.13039\/100007048","name":"Mayo Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Individuals with early-onset dysexecutive Alzheimer\u2019s disease (dAD) have high rates of failed performance validity testing (PVT), which can lead to symptom misinterpretation and misdiagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>The aim of this retrospective study is to evaluate rates of failure on a common PVT, the test of memory malingering (TOMM), in a sample of clinical patients with biomarker-confirmed early-onset dAD who completed neuropsychological testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified seventeen patients with an average age of symptom onset at 52.25\u00a0years old. Nearly fifty percent of patients performed below recommended cut-offs on Trials 1 and 2 of the TOMM. Four of six patients who completed outside neuropsychological testing were misdiagnosed with alternative etiologies to explain their symptomatology, with two of these patients\u2019 performances deemed unreliable based on the TOMM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Low scores on the TOMM should be interpreted in light of contextual and optimally biological information and do not necessarily rule out a neurodegenerative etiology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/arclin\/acac016","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T16:13:11Z","timestamp":1647447191000},"page":"1199-1207","source":"Crossref","is-referenced-by-count":10,"title":["Failed Performance on the Test of Memory Malingering and Misdiagnosis in Individuals with Early-Onset Dysexecutive Alzheimer\u2019s Disease"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6561-9870","authenticated-orcid":false,"given":"Nick","family":"Corriveau-Lecavalier","sequence":"first","affiliation":[{"name":"Department of Neurology, Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva C","family":"Alden","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychology, Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki H","family":"Stricker","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychology, Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M","family":"Machulda","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychology, Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic , Rochester, MN, USA"},{"name":"Department of Radiology, Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,4,14]]},"reference":[{"issue":"2","key":"2022082308580342400_ref1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jamaneurol.2019.3606","article-title":"Selective vulnerability of the nucleus basalis of Meynert among neuropathologic subtypes of Alzheimer disease","volume":"77","author":"Al-Shaikh","year":"2020","journal-title":"JAMA Neurology"},{"issue":"3","key":"2022082308580342400_ref2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/archneur.58.3.373","article-title":"Evaluation of CSF-tau and CSF-A\u03b242 as diagnostic markers for Alzheimer disease in clinical practice","volume":"58","author":"Andreasen","year":"2001","journal-title":"Archives of Neurology"},{"issue":"9926","key":"2022082308580342400_ref3","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0140-6736(13)62186-8","article-title":"Factitious disorders and malingering: Challenges for clinical assessment and management","volume":"383","author":"Bass","year":"2014","journal-title":"The Lancet"},{"issue":"3","key":"2022082308580342400_ref4","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11682-015-9409-1","article-title":"Neuroimaging as a biomarker in symptom validity and performance validity testing","volume":"9","author":"Bigler","year":"2015","journal-title":"Brain Imaging and Behavior"},{"key":"2022082308580342400_ref5","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-022-11025-x","article-title":"Phenotypic subtypes of progressive dysexecutive syndrome due to Alzheimer\u2019s disease: A series of clinical cases","author":"Corriveau-Lecavalier","year":"2022","journal-title":"Journal of Neurology"},{"issue":"10","key":"2022082308580342400_ref6","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1080\/13803395.2018.1472221","article-title":"Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered","volume":"40","author":"Davis","year":"2018","journal-title":"Journal of Clinical and Experimental Neuropsychology"},{"issue":"6","key":"2022082308580342400_ref7","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: The IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"The Lancet Neurology"},{"key":"2022082308580342400_ref8","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/B978-0-12-407794-2.00068-7","volume-title":"Neurobiology of language","author":"Fiez","year":"2016"},{"issue":"3","key":"2022082308580342400_ref9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/09084282.2013.787425","article-title":"Effort test performance in clinical acute brain injury, community brain injury, and epilepsy populations","volume":"21","author":"Hampson","year":"2014","journal-title":"Applied Neuropsychology: Adult"},{"issue":"9","key":"2022082308580342400_ref10","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1001\/jamaneurol.2021.2161","article-title":"Global prevalence of young-onset dementia: A systematic review and meta-analysis","volume":"78","author":"Hendriks","year":"2021","journal-title":"JAMA Neurology"},{"issue":"1","key":"2022082308580342400_ref11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00002093-199505000-00004","article-title":"FDG PET and differential diagnosis of dementia","volume":"9","author":"Herholz","year":"1995","journal-title":"Alzheimer Disease and Associated Disorders"},{"issue":"7","key":"2022082308580342400_ref12","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/13854046.2011.589409","article-title":"Use of trial 1 of the test of memory malingering (TOMM) as a screening measure of effort: Suggested discontinuation rules","volume":"25","author":"Hilsabeck","year":"2011","journal-title":"The Clinical Neuropsychologist"},{"issue":"2","key":"2022082308580342400_ref13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/13854040801945060","article-title":"Classification accuracy and predictive ability of the medical symptom validity test's dementia profile and general memory impairment profile","volume":"23","author":"Howe","year":"2009","journal-title":"The Clinical Neuropsychologist"},{"issue":"8","key":"2022082308580342400_ref14","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.52.8.1555","article-title":"Improved discrimination of AD patients using \u03b2-amyloid (1-42) and tau levels in CSF","volume":"52","author":"Hulstaert","year":"1999","journal-title":"Neurology"},{"issue":"4","key":"2022082308580342400_ref15","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer's & Dementia"},{"issue":"6","key":"2022082308580342400_ref16","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ana.22628","article-title":"An operational approach to National Institute on Aging\u2013Alzheimer's Association criteria for preclinical Alzheimer disease","volume":"71","author":"Jack","year":"2012","journal-title":"Annals of Neurology"},{"issue":"3","key":"2022082308580342400_ref17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jalz.2016.08.005","article-title":"Defining imaging biomarker cut points for brain aging and Alzheimer's disease","volume":"13","author":"Jack","year":"2017","journal-title":"Alzheimer's & Dementia"},{"key":"2022082308580342400_ref18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cortex.2017.09.018","article-title":"Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum","volume":"97","author":"Jones","year":"2017","journal-title":"Cortex"},{"issue":"1","key":"2022082308580342400_ref19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-29047-4","article-title":"A computational model of neurodegeneration in Alzheimer's disease","volume":"13","author":"Jones","year":"2022","journal-title":"Nature Communications"},{"key":"2022082308580342400_ref19a","volume-title":"Dementia rating Scale-2: DRS-2: professional manual","year":"2001"},{"issue":"7","key":"2022082308580342400_ref20","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/archneur.1991.00530190071018","article-title":"The short test of mental status: Correlations with standardized psychometric testing","volume":"48","author":"Kokmen","year":"1991","journal-title":"Archives of Neurology"},{"issue":"12","key":"2022082308580342400_ref21","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1017\/S1041610214001574","article-title":"Young onset dementia\u2013what does the name imply?","volume":"26","author":"Koopmans","year":"2014","journal-title":"International Psychogeriatrics"},{"issue":"1","key":"2022082308580342400_ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13854046.2020.1778790","article-title":"Performance validity in the dementia clinic: Specificity of validity tests when used individually and in aggregate across levels of cognitive impairment severity","volume":"36","author":"Martin","year":"2022","journal-title":"The Clinical Neuropsychologist"},{"issue":"1","key":"2022082308580342400_ref23","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/13854046.2019.1637027","article-title":"A systematic review and meta-analysis of the test of memory malingering in adults: Two decades of deception detection","volume":"34","author":"Martin","year":"2020","journal-title":"The Clinical Neuropsychologist"},{"issue":"1","key":"2022082308580342400_ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-15541-0","article-title":"Multimodal network dynamics underpinning working memory","volume":"11","author":"Murphy","year":"2020","journal-title":"Nature Communications"},{"key":"2022082308580342400_ref25","article-title":"A head-to-head comparison of cerebral blood flow SPECT and 18F-FDG PET in the diagnosis of Alzheimer's disease","author":"Nadebaum","year":"2020","journal-title":"Internal Medicine Journal"},{"issue":"4","key":"2022082308580342400_ref26","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"Journal of the American Geriatrics Society"},{"key":"2022082308580342400_ref27","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.neuroimage.2018.03.022","article-title":"Distinct functional and structural neural underpinnings of working memory","volume":"174","author":"Owens","year":"2018","journal-title":"NeuroImage"},{"issue":"4","key":"2022082308580342400_ref28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/arclin\/acz079","article-title":"Early cutoff criteria for strong performance on the test of memory malingering","volume":"35","author":"Polsinelli","year":"2020","journal-title":"Archives of Clinical Neuropsychology"},{"issue":"9","key":"2022082308580342400_ref29","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"issue":"6","key":"2022082308580342400_ref30","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/arclin\/acaa019","article-title":"Multidimensional malingering criteria for neuropsychological assessment: A 20-year update of the malingered neuropsychological dysfunction criteria","volume":"35","author":"Sherman","year":"2020","journal-title":"Archives of Clinical Neuropsychology"},{"issue":"4","key":"2022082308580342400_ref31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.acn.2003.04.001","article-title":"Detecting malingering: A survey of experts' practices","volume":"19","author":"Slick","year":"2004","journal-title":"Archives of Clinical Neuropsychology"},{"issue":"18","key":"2022082308580342400_ref32","doi-asserted-by":"crossref","first-page":"e2272","DOI":"10.1212\/WNL.0000000000011772","article-title":"Age-at-onset and APOE-related heterogeneity in pathologically confirmed sporadic Alzheimer disease","volume":"96","author":"Smirnov","year":"2021","journal-title":"Neurology"},{"issue":"8","key":"2022082308580342400_ref33","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1080\/13854046.2012.722230","article-title":"Confronting patients about insufficient effort: The impact on subsequent symptom validity and memory performance","volume":"26","author":"Suchy","year":"2012","journal-title":"The Clinical Neuropsychologist"},{"issue":"6","key":"2022082308580342400_ref34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13854046.2021.1896036","article-title":"American Academy of Clinical Neuropsychology (AACN) 2021 consensus statement on validity assessment: Update of the 2009 AACN consensus conference statement on neuropsychological assessment of effort, response bias, and malingering","volume":"35","author":"Sweet","year":"2021","journal-title":"The Clinical Neuropsychologist"},{"issue":"3","key":"2022082308580342400_ref35","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0887-6177(03)00078-7","article-title":"The test of memory malingering (TOMM): Normative data from cognitively intact, cognitively impaired, and elderly patients with dementia","volume":"19","author":"Teichner","year":"2004","journal-title":"Archives of Clinical Neuropsychology"},{"key":"2022082308580342400_ref36","volume-title":"Test of memory malingering","author":"Tombaugh","year":"1996"},{"issue":"1","key":"2022082308580342400_ref37","doi-asserted-by":"crossref","first-page":"fcaa068","DOI":"10.1093\/braincomms\/fcaa068","article-title":"Progressive dysexecutive syndrome due to Alzheimer\u2019s disease: A description of 55 cases and comparison to other phenotypes","volume":"2","author":"Townley","year":"2020","journal-title":"Brain Communications"},{"issue":"8","key":"2022082308580342400_ref38","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.mayocp.2019.01.043","article-title":"Comparison of the short test of mental status and the Montreal cognitive assessment across the cognitive spectrum","volume":"49","author":"Townley","year":"2019","journal-title":"Mayo Clinic Proceedings"},{"issue":"3","key":"2022082308580342400_ref39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41583-021-00428-w","article-title":"Cognitive and behavioural flexibility: Neural mechanisms and clinical considerations","volume":"22","author":"Uddin","year":"2021","journal-title":"Nature Reviews Neuroscience"},{"issue":"5","key":"2022082308580342400_ref40","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41591-021-01309-6","article-title":"Four distinct trajectories of tau deposition identified in Alzheimer\u2019s disease","volume":"27","author":"Vogel","year":"2021","journal-title":"Nature Medicine"},{"issue":"7","key":"2022082308580342400_ref41","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/13854046.2014.960454","article-title":"Effects of severity of dementia on a symptom validity measure","volume":"28","author":"Walter","year":"2014","journal-title":"The Clinical Neuropsychologist"},{"issue":"39","key":"2022082308580342400_ref42","doi-asserted-by":"crossref","first-page":"10060","DOI":"10.1523\/JNEUROSCI.1476-16.2016","article-title":"Dissociable changes of frontal and parietal cortices in inherent functional flexibility across the human life span","volume":"36","author":"Yin","year":"2016","journal-title":"Journal of Neuroscience"}],"container-title":["Archives of Clinical Neuropsychology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/acn\/article-pdf\/37\/6\/1199\/45498452\/acac016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/acn\/article-pdf\/37\/6\/1199\/45498452\/acac016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T05:00:49Z","timestamp":1661230849000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/acn\/article\/37\/6\/1199\/6567705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,14]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,4,14]]},"published-print":{"date-parts":[[2022,8,23]]}},"URL":"https:\/\/doi.org\/10.1093\/arclin\/acac016","relation":{},"ISSN":["1873-5843"],"issn-type":[{"value":"1873-5843","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9]]},"published":{"date-parts":[[2022,4,14]]}}}